LLY

715.06

-1.34%↓

JNJ

152.52

-0.44%↓

ABBV

182.34

+0.35%↑

NVO

68.13

-0.07%↓

UNH

296.46

-2.25%↓

LLY

715.06

-1.34%↓

JNJ

152.52

-0.44%↓

ABBV

182.34

+0.35%↑

NVO

68.13

-0.07%↓

UNH

296.46

-2.25%↓

LLY

715.06

-1.34%↓

JNJ

152.52

-0.44%↓

ABBV

182.34

+0.35%↑

NVO

68.13

-0.07%↓

UNH

296.46

-2.25%↓

LLY

715.06

-1.34%↓

JNJ

152.52

-0.44%↓

ABBV

182.34

+0.35%↑

NVO

68.13

-0.07%↓

UNH

296.46

-2.25%↓

LLY

715.06

-1.34%↓

JNJ

152.52

-0.44%↓

ABBV

182.34

+0.35%↑

NVO

68.13

-0.07%↓

UNH

296.46

-2.25%↓

Search

STAAR Surgical Co

Chiusa

SettoreSettore sanitario

18.74 1.63

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

18.23

Massimo

18.91

Metriche Chiave

By Trading Economics

Entrata

-20M

-54M

Vendite

-6.4M

43M

P/E

Media del settore

55.443

54.533

EPS

-1.005

Margine di Profitto

-127.289

Dipendenti

1,157

EBITDA

-43M

-71M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+3.74% upside

Dividendi

By Dow Jones

Utili prossimi

6 ago 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

160M

953M

Apertura precedente

17.11

Chiusura precedente

18.74

Notizie sul Sentiment di mercato

By Acuity

60%

40%

337 / 382 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

STAAR Surgical Co Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

21 mag 2025, 23:25 UTC

Azioni calde

Stocks to Watch: Navitas Semiconductor, Urban Outfitters, Lumen Technologies, LiveRamp

21 mag 2025, 21:57 UTC

Acquisizioni, Fusioni, Takeovers

AT&T to Buy Lumen's Mass Markets Fiber Business for $5.75 Billion -- Update

21 mag 2025, 21:29 UTC

Acquisizioni, Fusioni, Takeovers

Millicom to Acquire Telefónica's Operations in Uruguay

21 mag 2025, 21:01 UTC

I principali Market Mover

Nvidia Selects Navitas Semiconductor to Work on Next-Generation 800V HVDC Architecture

21 mag 2025, 23:49 UTC

Discorsi di Mercato

Gold Edges Higher on Possible Investor Shift Away From Government Bonds -- Market Talk

21 mag 2025, 23:37 UTC

Discorsi di Mercato

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

21 mag 2025, 23:33 UTC

Acquisizioni, Fusioni, Takeovers

Vigil Neuroscience: Iluzanebart Return to Licensor Amgen to Occur Prior to Closing of Sanofi Deal

21 mag 2025, 23:32 UTC

Acquisizioni, Fusioni, Takeovers

Vigil Neuroscience Sees Sanofi Deal Strengthening Development Path for Oral Small Molecule TREM2 Agonist Program

21 mag 2025, 23:32 UTC

Acquisizioni, Fusioni, Takeovers

Vigil Neuroscience: Shareholders to Get Up to $10 a Share in Sanofi Deal >SAN.FR VIGL

21 mag 2025, 23:32 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

James Hardie's Weak Update Spurs Questions Before AZEK Vote -- Market Talk

21 mag 2025, 23:31 UTC

Acquisizioni, Fusioni, Takeovers

Samsung Biologics: Remaining Entity to Focus on Contract Development & Manufacturing Organization Business

21 mag 2025, 23:30 UTC

Acquisizioni, Fusioni, Takeovers

Samsung Biologics: Spun-Off Entity Tentatively Named Samsung Episholdings

21 mag 2025, 23:30 UTC

Acquisizioni, Fusioni, Takeovers

Samsung Biologics: Separated Business Entity to Focus on R&D Affiliate Samsungbioepis, New Investment

21 mag 2025, 23:29 UTC

Acquisizioni, Fusioni, Takeovers

Samsung Biologics to Spin off R&D Segment Into Separate Holdings Company

21 mag 2025, 23:28 UTC

Utili

Singtel to Finance Buybacks Via Excess Capital Generated From Asset Recycling >Z74.SG

21 mag 2025, 23:27 UTC

Utili

Singtel Sets Up S$2.0B Share-Buyback Program >Z74.SG

21 mag 2025, 23:26 UTC

Utili

Singtel: Net Rose Due to Exceptional Gain From Partial Divestment of Comcentre Headquarters >Z74.SG

21 mag 2025, 23:26 UTC

Utili

Singtel FY25 Rev S$14.15B Vs. S$14.13B >Z74.SG

21 mag 2025, 23:26 UTC

Utili

Singtel FY25 Net S$4.02B Vs. Net S$795.0M >Z74.SG

21 mag 2025, 23:23 UTC

Acquisizioni, Fusioni, Takeovers

Sanofi: VGL101, Vigil's Second Molecule Program, Isn't Being Acquired

21 mag 2025, 23:22 UTC

Notizie principali

Walmart to Cut 1,500 Corporate Jobs in Restructuring -- WSJ

21 mag 2025, 23:22 UTC

Acquisizioni, Fusioni, Takeovers

Sanofi Sees No Effect From Vigil Deal on 2025 Outlook >SAN.FR

21 mag 2025, 23:20 UTC

Acquisizioni, Fusioni, Takeovers

Sanofi: Vigil Deal Enhances Early-Stage Pipeline, Includes VG-3927, Which Will Be Evaluated in Alzheimer's Disease Study

21 mag 2025, 23:18 UTC

Acquisizioni, Fusioni, Takeovers

Sanofi to Buy Vigil Neuroscience for $8 a Share at Closing >SAN.FR VIGL

21 mag 2025, 23:04 UTC

Notizie principali

EV Owners Face Annual Fee Under Proposed Tax Bill -- Barrons.com

21 mag 2025, 21:46 UTC

Notizie principali

NBCUniversal Bids for MLB Rights That Were Dropped by ESPN -- WSJ

21 mag 2025, 21:42 UTC

Notizie principali
Acquisizioni, Fusioni, Takeovers

AT&T to Buy Lumen's Mass Markets Fiber Business for $5.75B -- Update

21 mag 2025, 21:14 UTC

Acquisizioni, Fusioni, Takeovers

Millicom to Acquire Telefónica's Ops in Uruguay

21 mag 2025, 21:07 UTC

Notizie principali

NBCUniversal Bids for Major League Baseball Rights ESPN Dropped, Sources Say -- WSJ

21 mag 2025, 21:06 UTC

Acquisizioni, Fusioni, Takeovers

Uber Stock Is Dropping. Blame Elon Musk and Tesla. -- Barrons.com

Confronto tra pari

Modifica del prezzo

STAAR Surgical Co Previsione

Obiettivo di Prezzo

By TipRanks

3.74% in crescita

Previsioni per 12 mesi

Media 19.14 USD  3.74%

Alto 27 USD

Basso 13 USD

Basato su 10 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per STAAR Surgical Co - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

10 ratings

2

Acquista

7

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

18.604 / 20.07Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Very Strong Bullish Evidence

A lungo termine

No Evidence

Sentiment

By Acuity

337 / 382 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove ribassiste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.